[1] ZABOTTI A, MANDL P, ZAMPOGNA G, et al. One year in review 2018: ultrasonography in rheumatoid arthritis and psoriatic arthritis[J]. Clin Exp Rheumatol,2018,36(4):519-525
[2] COHEN S B, ALTEN R, KAMEDA H, et al. A randomized controlled trial comparing PF-06438179/GP1111 (an infliximab biosimilar) and infliximab reference product for treatment of moderate to severe active rheumatoid arthritis despite methotrexate therapy[J]. Arthritis Res Ther,2018,20(1):155
[3] ALLEVA J M, DIEDRICHS P C, HALLIWELL E, et al. More than my RA: A randomized trial investigating body image improvement among women with rheumatoid arthritis using a functionality-focused intervention program[J]. J Consult Clin Psychol,2018,86(8):666-676
[4] 胡晓敏, 宗英, 余珊珊, 等. 类风湿关节炎治疗药物的研发进展及趋势[J]. 中国新药杂志, 2017, 26(1):36-43
[5] 钱仲华, 孔小阳, 钱唯韵, 等. 舒适护理在老年类风湿关节炎患者中的应用[J]. 实用老年医学, 2016, 30(1):85-86
[6] 张挺, 周艳, 李永吉, 等. 托珠单抗与英夫利西单抗在类风湿关节炎治疗中的疗效评价[J]. 全科医学临床与教育, 2017, 15(3):255-258
[7] TANAKA Y, KAMEDA H, SAITO K, et al. Effect of subcutaneous tocilizumab treatment on work/housework status in biologic-naïve rheumatoid arthritis patients using inverse probability of treatment weighting: FIRST ACT-SC study[J]. Arthritis Res Ther,2018,20(1):151
[8] ARNETT F C, EDWORTHY S M, BLOCH D A, et al. The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis[J]. Arthritis Rheum,1988,31(3):315-324
[9] 饶莉, 石哲群, 杨静. 痹祺胶囊联合托珠单抗治疗类风湿性关节炎的临床疗效观察[J]. 中药材, 2015, 38(4):866-868
[10] OTSUKA Y, KIYOHARA C, KASHIWADO Y, et al. Effects of tumor necrosis factor inhibitors and tocilizumab on the glycosylated hemoglobin levels in patients with rheumatoid arthritis; an observational study[J]. PLoS One,2018,13(4):e0196368
[11] 毕东敏, 魏建芬, 张万壮, 等. 麝香乌龙丸对中医不同证型类风湿关节炎血清MIF、ICAM-1、VCAM-1表达的影响[J]. 湖南师范大学学报(医学版), 2016, 13(4):129-132
[12] CHOY E, CAPORALI R, XAVIER R, et al. Subcutaneous tocilizumab in rheumatoid arthritis: findings from the common-framework phase 4 study programme TOZURA conducted in 22 countries[J]. Rheumatology (Oxford),2018,57(6):1129
[13] 杨洋, 李伟杰, 刘金玉, 等. 托珠单抗单用与联合甲氨蝶呤治疗类风湿性关节炎疗效和安全性比较的Meta分析[J]. 中国药师, 2017, 20(5):854-859
[14] 陈乐锋, 马剑达, 韦秀宁, 等. 托珠单抗联合治疗对难治性类风湿关节炎患者病情活动及心理状态的疗效观察[J]. 中华风湿病学杂志, 2015, 19(2):115-118
[15] 肖雪野. 抗CCP抗体、补体及免疫球蛋白在类风湿性关节炎病理过程中的变化及临床意义[J]. 海南医学院学报, 2017, 23(4):514-517
[16] 刘军慧, 邹蕾, 罗妍. TCZ联合IMD治疗RRA的疗效和对ESR、CRP、IgG水平的影响[J]. 西南国防医药, 2018, 28(5):406-409
[17] 罗小红, 周娟, 洪学志, 等. 青蒿治疗难治性类风湿关节炎患者的疗效及对TH17/Treg细胞因子的影响[J]. 中国医院药学杂志, 2017, 37(24):2451-2455